OR8S1: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: OR8S1

NCBI ID: G341568

OR8S1

Other Name(s): OR8S1_HUMAN | Olfactory receptor family 8 subfamily S member 1 | olfactory receptor family 8 subfamily S member 1 | Olfactory receptor 8S1

OR8S1: A Potential Drug Target Or Biomarker for Various Diseases

OR8S1 (OR8S1_HUMAN), a protein that is expressed in various tissues of the human body, including the brain, heart, and skeletal muscles, has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

The OR8S1 protein is a member of the superfamily of G-protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play an important role in cellular signaling. GPCRs are involved in a wide range of physiological processes in the body, including sensory perception, neurotransmission, and hormone signaling.

OR8S1 is a 21-kDa protein that is expressed in the brain, heart, and skeletal muscles. It is highly conserved across different species, and its amino acid sequence is similar to that of other GPCRs. OR8S1 is localized to the endoplasmic reticulum (ER) and appears to be involved in the regulation of cellular processes, including cell signaling, cell adhesion, and neurotransmission.

OR8S1 has been shown to be involved in a variety of physiological processes in the body. For example, OR8S1 has been shown to play a role in the regulation of neurotransmitter release from nerve terminals, which is important for the function of the nervous system. OR8S1 has also been shown to be involved in the regulation of muscle contractions and the maintenance of muscle mass, which is important for maintaining posture and movement.

In addition to its involvement in physiological processes, OR8S1 has also been shown to be involved in the development and progression of various diseases. For example, OR8S1 has been shown to be overexpressed in various types of cancer, including breast, lung, and ovarian cancer. This suggests that OR8S1 may be a potential drug target for these diseases.

OR8S1 has also been shown to be involved in the regulation of cellular signaling pathways that are important for the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. For example, OR8S1 has been shown to play a role in the regulation of the neurotransmitter tyrosine, which is involved in the development of neurotransmitter depletion in neurodegenerative diseases.

In addition to its involvement in neurodegenerative diseases, OR8S1 has also been shown to be involved in the regulation of other physiological processes that are important for overall health and wellbeing. For example, OR8S1 has been shown to play a role in the regulation of inflammation, which is important for maintaining immune function and preventing infection.

In conclusion, OR8S1 is a protein that is expressed in various tissues of the human body and is involved in a wide range of physiological processes that are important for overall health and wellbeing. Its involvement in the regulation of neurotransmission, muscle contractions, and cellular signaling pathways makes it a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Further research is needed to fully understand the role of OR8S1 in these diseases and to develop effective treatments.

Protein Name: Olfactory Receptor Family 8 Subfamily S Member 1

Functions: Odorant receptor

The "OR8S1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR8S1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets